Trial Profile

A First-In-Human Phase 1b, Open-Label Trial to Evaluate Safety and Tolerability of a Novel Somatic Cell Therapy, AmnioPul-02,in Subjects With Confirmed COVID-19 or Other Viral Lower Respiratory Tract Infections

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 16 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

08 Mar 2023 Status changed from planning to completed.
12 Apr 2022 New trial record
05 Apr 2022 According to Amniotics media release, the company is working with the clinical sites to prepare for initiation of recruitment and dosing of the patients in this trial..

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com